Information Journal Paper
APA:
Copy. (2017). Metabolomics in Alzheimer’ s disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1071(-), 75-92. SID. https://sid.ir/paper/724114/en
Vancouver:
Copy. Metabolomics in Alzheimer’ s disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences[Internet]. 2017;1071(-):75-92. Available from: https://sid.ir/paper/724114/en
IEEE:
Copy, “Metabolomics in Alzheimer’ s disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 1071, no. -, pp. 75–92, 2017, [Online]. Available: https://sid.ir/paper/724114/en